KI
UTHR icon

Kula Investments’s United Therapeutics UTHR Stock Holding History

Kula Investments’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$218K Buy
+975
New +$240K 0.05% 546

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Kula Investments's UTHR Position: Q1 2023 in Review

Kula Investments opened a new position in United Therapeutics (UTHR) in Q1 2023: 975 shares worth $218K. The stake represents 0.05% of the portfolio and ranks #546 among its holdings.

506 funds tracked by Wall St. Rank hold UTHR as of Q1 2023.

  • Kula Investments held 975 shares of United Therapeutics worth $218K as of Q1 2023.
  • United Therapeutics was a new Kula Investments position in Q1 2023.
  • United Therapeutics made up 0.05% of Kula Investments's portfolio in Q1 2023, its #546 holding.
  • 506 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2023.

Based on Kula Investments's 13F filing for Q1 2023, filed 15 May 2023.